Kirr Marbach & Co’s Eli Lilly LLY Stock Holding History

Kirr Marbach & Co’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.53M	Hold	2,113	–	–	0.43%	43
2026 Q1	$1.94M	Sell	2,113 -5	-0.2%	-$5.07K	0.35%	43
2025 Q4	$2.28M	Buy	2,118 +50	+2%	+$47.8K	0.44%	41
2025 Q3	$1.58M	Hold	2,068	–	–	0.28%	43
2025 Q2	$1.61M	Hold	2,068	–	–	0.32%	43
2025 Q1	$1.71M	Hold	2,068	–	–	0.4%	41
2024 Q4	$1.6M	Hold	2,068	–	–	0.35%	43
2024 Q3	$1.83M	Hold	2,068	–	–	0.41%	39
2024 Q2	$1.87M	Hold	2,068	–	–	0.45%	39
2024 Q1	$1.61M	Sell	2,068 -3,714	-64%	-$2.64M	0.39%	38
2023 Q4	$3.37M	Hold	5,782	–	–	0.88%	32
2023 Q3	$3.11M	Buy	5,782 +88	+2%	+$45.3K	0.88%	34
2023 Q2	$2.67M	Hold	5,694	–	–	0.74%	39
2023 Q1	$1.96M	Hold	5,694	–	–	0.61%	39
2022 Q4	$2.08M	Sell	5,694 -359	-6%	-$127K	0.65%	39
2022 Q3	$1.96M	Hold	6,053	–	–	0.66%	40
2022 Q2	$1.96M	Hold	6,053	–	–	0.62%	41
2022 Q1	$1.73M	Hold	6,053	–	–	0.47%	43
2021 Q4	$1.67M	Hold	6,053	–	–	0.44%	39
2021 Q3	$1.4M	Sell	6,053 -513	-8%	-$127K	0.41%	38
2021 Q2	$1.51M	Hold	6,566	–	–	0.43%	36
2021 Q1	$1.23M	Sell	6,566 -30	-0.5%	-$5.87K	0.36%	39
2020 Q4	$1.11M	Sell	6,596 -20	-0.3%	-$2.99K	0.35%	40
2020 Q3	$979K	Sell	6,616 -50	-0.8%	-$7.74K	0.36%	39
2020 Q2	$1.09M	Sell	6,666 -467	-7%	-$71.7K	0.39%	41
2020 Q1	$989K	Sell	7,133 -160	-2%	-$22K	0.42%	44
2019 Q4	$959K	Buy	7,293 +200	+3%	+$23.2K	0.22%	44
2019 Q3	$793K	Hold	7,093	–	–	0.19%	45
2019 Q2	$786K	Hold	7,093	–	–	0.19%	45
2019 Q1	$920K	Hold	7,093	–	–	0.22%	44
2018 Q4	$821K	Buy	7,093 +60	+0.9%	+$6.7K	0.23%	45
2018 Q3	$755K	Hold	7,033	–	–	0.17%	43
2018 Q2	$600K	Sell	7,033 -150	-2%	-$12.3K	0.13%	45
2018 Q1	$556K	Hold	7,183	–	–	0.12%	48
2017 Q4	$607K	Hold	7,183	–	–	0.12%	46
2017 Q3	$614K	Sell	7,183 -417	-5%	-$34.2K	0.13%	44
2017 Q2	$625K	Hold	7,600	–	–	0.14%	43
2017 Q1	$639K	Hold	7,600	–	–	0.14%	45
2016 Q4	$559K	Hold	7,600	–	–	0.12%	46
2016 Q3	$610K	Hold	7,600	–	–	0.12%	47
2016 Q2	$599K	Hold	7,600	–	–	0.13%	48
2016 Q1	$547K	Sell	7,600 -175	-2%	-$13.2K	0.11%	46
2015 Q4	$655K	Hold	7,775	–	–	0.13%	47
2015 Q3	$651K	Hold	7,775	–	–	0.13%	43
2015 Q2	$649K	Hold	7,775	–	–	0.11%	44
2015 Q1	$565K	Hold	7,775	–	–	0.1%	42
2014 Q4	$536K	Hold	7,775	–	–	0.1%	42
2014 Q3	$504K	Hold	7,775	–	–	0.09%	42
2014 Q2	$483K	Sell	7,775 -600	-7%	-$35.8K	0.09%	40
2014 Q1	$493K	Sell	8,375 -500	-6%	-$27.9K	0.09%	46
2013 Q4	$453K	Hold	8,875	–	–	0.08%	43
2013 Q3	$447K	Hold	8,875	–	–	0.09%	44
2013 Q2	$436K	Buy	+8,875	New	+$483K	0.09%	44

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Kirr Marbach & Co's LLY Position: Q2 2026 in Review

Kirr Marbach & Co held its Eli Lilly (LLY) position steady in Q2 2026 at 2,113 shares worth $2.53M. The position accounts for 0.43% of the portfolio, ranked #43.

Kirr Marbach & Co first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.37M in Q4 2023. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Kirr Marbach & Co held 2,113 shares of Eli Lilly worth $2.53M as of Q2 2026.
Kirr Marbach & Co left its Eli Lilly share count unchanged in Q2 2026.
Eli Lilly made up 0.43% of Kirr Marbach & Co's portfolio in Q2 2026, its #43 holding.
Kirr Marbach & Co first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
Kirr Marbach & Co's Eli Lilly position peaked at $3.37M in Q4 2023.
2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Kirr Marbach & Co's 13F filing for Q2 2026, filed 14 Jul 2026.